Stephen H. Petersdorf, MD

Stephen H. Petersdorf, MD

Associate Professor
Department of Medicine
Division of Oncology

Mailing Address

Seattle Cancer Care Alliance
825 Eastlake Ave E
Seattle, WA 98109

Admin Contact

Tina Bogne
Fax: 206.288.1130

Specialty / Expertise

Leukemia, Lymphoma and other Hematologic Malignancies

Research Interests

Developing new therapies for the treatment of acute lymphoblastic leukemia, chronic myelogenous leukemia, and lymphoma phase I studies.

Current Research Projects



Dr. Petersdorf received both his AB and MD from Brown University, Providence, RI. He completed his Internal Medicine Residency at the University of Washington, Seattle, WA. He was a Post-Doctoral Fellow in Hematology at the University of Washington, Seattle, WA.

Selected Publications

Inamoto Y, Fefer A, Sandmaier BM, Gooley TA, Warren EH, Petersdorf SH, Sanders JE, Storb RF, Appelbaum FR, Martin PJ, Flowers ME.  A Phase I/II Study of Chemotherapy followed by donor lymphocyte infusion plus Interleukin-2 for Relapsed Acute Leukemia after Allogeneic Hematopoietic Cell Transplantation.  Biol Blood Marrow Transplant 2011 Jan 10.  [Epub ahead of print]

Gopal AK, Press OW, Shustov AR, Petersdorf SH, Gooley TA, Daniels JT, Garrison MA, Gjerset GF, Lonergan M, Murphy AE, Smith JC, Pagel JM.. Efficacy and safety of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed/refractory lymphoma: a prospective multi-center phase II study by the Puget Sound Oncology  Consortium.  Leuk Lymphoma. 2010 Aug;51(8):1523-9. PMCID: PMC3018339

Ho PA, Alonzo TA, Kopecky KJ, Miller KL, Kuhn J, Zeng R, Gerbing RB, Raimondi SC, Hirsch BA, Oehler V, Hurwitz CA, Franklin JL, Gamis AS, Petersdorf SH, Anderson JE, Reaman GH, Baker LH, Willman CL, Bernstein ID, Radich JP, Appelbaum FR, Stirewalt DL, Meshinchi S.  Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study.  Leukemia. 2010 May;24(5);909-13.Epub 2010 Apr 8.

Scott BL, Ramakrishnan A, Fosdal M, Storer B, Becker P, Petersdorf S, Deeg HJ.  Anti-thymocyte globulin plus etanercept as therapy for myelodysplastic syndromes (MDS): a phase II study.  Br J Haematol. 2010 Jun; 149(5):706-10.Epub 2010 Mar 16.

Scott BL, Ramakrishnan A, Storer B, Becker PS, Petersdorf S, Estey EH, Deeg HJ.  Prolonged responses in patients with MDS and CMML treated with azacitidine and etanercept.  Br J Haematol.  2010 Mar; 148(6):944-7. Epub 2010 Jan 7.

Kantarjian HM, Erba HP, Claxton D, Arrellano M, Lyons RM, Kovascovics T, Gabrilove J, Craig M, Douer D, Maris M, Petersdorf S, Shami PJ, Yeager AM, Eckert S, Abichandani R, Faderl S.  Phase II study of clofarabine monotherapy in previously untreated older adults with acute myeloid leukemia and unfavorable prognostic factors.  J Clin Oncol.  2010Feb 1;28(4):549-55.

Becker PS, Kopecky KJ, Wilks AN, Chien S, Harlan JM, Willman CL, Petersdorf SH, Stirewalt DL, Papayannopoulou T, Appelbaum FR. Very late antigen-4 function of myeloblasts correlates with improved overall survival for patients with acute myeloid leukemia.  Blood. 113(4):866-74, 2009.

Gopal AK, Metcalfe TL, Gooley TA, Pagel JM, Petersdorf SH, Bensinger WI, Holmberg L, Maloney DG, Press OW.  High-dose therapy and autologous stem cell transplantation for chemoresistant Hodgkin lymphoma: the Seattle experience.  Cancer 2008 Sep 15;113(6):1344-50.  PMCID: PMC2700660
[The following link will open in a new window. PubMed Abstract ]

Feldman EJ, Cortes J, DeAngelo DJ, Holyoake T, Simonsson B, O'Brien SG, Reiffers J, Turner AR, Roboz GJ, Lipton JH, Maloisel F, Colombat P, Martinelli G, Nielsen JL, Petersdorf S, Guilhot F, Barker J, Kirschmeier P, Frank E, Statkevich P, Zhu Y, Loechner S, List A. On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia.  Leukemia. 22(9):1707-11, 2008.
[The following link will open in a new window. PubMed Abstract ]

Blumenthal DT, Rankin C, Eyre HJ, Livingston RB, Spence AM, Stelzer KJ, Rushing EJ, Berger MS, Rivkin SE, Cohn AL, Petersdorf SH.  External beam irradiation and the combination of cisplatin and carmustine followed by carmustine alone for the treatment of high-grade glioma: a phase 2 Southwest Oncology Group trial. Cancer. 113(3):559-65, 2008.
[The following link will open in a new window. PubMed Abstract ]

Till BG, Gooley TA, Crawford N, Gopal AK, Maloney DG, Petersdorf SH, Pagel JM, Holmberg L, Bensinger W, Press OW.  Effect of remission status and induction chemotherapy regimen on outcome of autologous stem cell transplantation for mantle cell lymphoma. Leukemia and Lymphoma 2008. Jun:49(6):1017-8. 
[The following link will open in a new window. PubMed Abstract ]

Thompson JA, Fisher RI, Leblanc M, Forman SJ, Press OW, Unger JM, Nademanee AP, Stiff PJ, Petersdorf SH, Fefer A.  Total body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood stem-cell transplantation followed by randomization to therapy with interleukin-2 versus observation for patients with non-Hodgkin lymphoma: results of a phase 3 randomized trial by the Southwest Oncology Group (SWOG 9438).  Blood. 111(8):4048-54, 2008.
[The following link will open in a new window. PubMed Abstract ]

Stewart FM, Wasserman RL, Bloomfield CD, Petersdorf SH, Witherspoon RP, Appelbaum FR, Ziskind A, McKenna B, Dodson JM, Weeks J, Vaughan WP,  Storer B, Perkel S, and Waldinger M. Benchmarks in Clinical Productivity: A National Comprehensive Cancer Network Survey.  J Oncology Practice 3: 2–8, 2007.

Gopal AK, Rajendran JG, Gooley TA, Pagel JM, Fisher DR, Petersdorf  SH, Maloney DG, Eary JF, Appelbaum FR and Press OW. High-dose (131-I) tositumomab (anti CD20) radioimmunotherapy and autologous hematopoietic stem- cell transplantation for adults > or = 60 years old with relapsed or refractory B-cell lymphoma. J Clin Oncol.  2007.  25(11):1396-1402.

Keeney GE, Gooley TA, Pham RN, Press OW, Pagel JM, Petersdorf SH, Maloney  DG, Bensinger W, Holmberg L, Gopal AK.  The pretransplant Follicular Lymphoma International Prognostic Index is associated with survival of follicular lymphoma patients undergoing autologous hematopoietic stem cell transplantation.  Leuk Lymphoma. 48:1961-7, 2007. 

Pham RN, Gooley TA, Keeney GE, Press OW, Pagel JM, Greisman HA, Bensinger  WI, Holmberg LA, Petersdorf SH, Maloney DG, Gopal AK.  The impact of histologic grade on the outcome of high-dose therapy and autologous stem cell transplantation for follicular lymphoma. Bone Marrow Transplant. 2007. 40:1039-44.      

Petersdorf SH, Rankin C, Head DR, Terebelo HR, Willman CL, Balcerzak SP, Karnad AB, Dakhil SR, Appelbaum FR. Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (SWOG-9500). Am J Hematol. 82:1056-62, 2007.

Appelbaum FR, Gundacker HM, Head DR, Slovak ML, Willman CL, Godwin JE, Anderson JE, Petersdorf SH. Age and acute myeloid leukemia. Blood.  1; 107(9): 3481-5, 2006.

Balducci L, Cohen HJ, Engstrom PF, Ettinger DS, Halter J, Gordon LI, Kiel K, Kneier A, Lim D, Petersdorf SH, Rosenthal R, Silliman R, Vose JM, Walker MJ, Zachariah B: National Comprehensive Cancer Network. Senior adult Oncology clinical practice guidelines in oncology. J Natl Compr Canc Netw, 4:572-90, 2005.

Epstein JB, Truelove EL, Hanson-Huggins K, Mancl LA, Chen A, Press OW, Petersdorf SH, Fritsche TR, Epstein JD. Topical polyene antifungals in hematopoietic cell transplant patients: tolerability and efficacy. Support Care  Cancer. 12(7): 517-25, 2004.

Last updated: May 2011